Urofollitropin action and adaptation symptoms? 【Kang Yuan】

　　Urofollitropin is indicated for anovulatory patients, including polycystic ovary syndrome, who have not responded to clomiphene citrate therapy. Its treatment aims to produce a single mature follicle, which stimulates the growth of the follicle. It can also be used in assisted reproductive technology ovulation-stimulated patients to stimulate the maturation of multiple follicles in the ovary. During medication, be sure to pay attention to the ingredients contained in this product, and patients with allergic reactions should not use it. Patients who are pregnant or breastfeeding should not be used. Primary ovarian failure should not be used. Undiagnosed vaginal bleeding, uterine fibroids, and patients who are not easy to conceive are contraindicated.

　　The above is the relevant content summarized by the editor of Kangyuan Company. If you want to know more, please continue to follow us. We will regularly update you about Human chorionic gonadotropin, Human Menopausal Gonadotropin supplier, Urofollitropin price, Urokinase manufacturer, and Hormone API Manufacturer Related content, I hope to help you.